-
Je něco špatně v tomto záznamu ?
Aspartate-β-hydroxylase and hypoxia marker expression in head and neck carcinomas: implications for HPV-associated tumors
J. Smahelova, B. Pokryvkova, E. Stovickova, M. Grega, O. Vencalek, M. Smahel, V. Koucky, S. Malerova, J. Klozar, R. Tachezy
Status neindexováno Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
Inter-Excellence programme (No. LTAUSA18003)
Ministry of Education, Youth and Sports, Czech Republic
Programme EXCELES, ID Project No. LX22NPO5103
European Union - Next Generation EU
SVV260679
Charles University, Prague, Czech Republic
NLK
BioMedCentral
od 2006-12-01
BioMedCentral Open Access
od 2006
Directory of Open Access Journals
od 2006
Free Medical Journals
od 2006
PubMed Central
od 2006
Europe PubMed Central
od 2006
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2006-01-01
Open Access Digital Library
od 2006-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2006
Springer Nature OA/Free Journals
od 2006-12-01
- Publikační typ
- časopisecké články MeSH
BACKGROUND: A proportion of head and neck carcinomas (HNSCCs) are induced by high-risk human papillomaviruses (HPVs) and are associated with better patient outcomes compared to patients with HNSCCs related to tobacco and alcohol abuse. In the microenvironment of solid tumors, including HNSCCs, oxygen levels are often reduced, and a hypoxic state is induced. This can lead to a poor treatment response and a worse patient prognosis. One of the hypoxia-responsive genes is aspartate-β-hydroxylase (ASPH), whose activity promotes the growth, invasiveness, and metastasis of many types of solid tumors. METHODS: In our study, HNSCC samples were analyzed for the expression of ASPH and selected endogenous hypoxia markers by real-time PCR and/or multiplex fluorescence immunohistochemistry. RESULTS: Except for the EPAS1 gene, which had higher mRNA expression in the HPV-negative group of HNSCC (p < 0.05), we found no other differences in the expression of the tested genes that were related to HPV status. On the contrary, a statistically significantly higher number of cells producing ASPH (p < 0.0001), HIF1A (p < 0.0001), GLUT1 (p < 0.0001), and MMP13 (p < 0.05) proteins were detected in the HPV-positive tumor group than in the HPV-negative sample group. All the evaluated markers, except for MMP9/13, were more abundant in the tumor parenchyma than in the tumor stroma. The Cox proportional hazard models showed that increased numbers of cells with GLUT1 and HIF1A protein expression were positive prognostic markers for overall and disease-specific survival in patients independent of HPV tumor status. CONCLUSION: The study examined HNSCC samples and found that elevated ASPH and hypoxia marker proteins, typically associated with poor prognosis, may actually indicate active HPV infection, the strongest prognostic factor in HNSCC patients. In cases where HPV status is uncertain, increased expression of HIF1A and GLUT1 can serve as positive prognostic factors.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24012571
- 003
- CZ-PrNML
- 005
- 20240726151403.0
- 007
- ta
- 008
- 240723s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13027-024-00588-1 $2 doi
- 035 __
- $a (PubMed)38858774
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Smahelova, Jana $u Department of Genetics and Microbiology, Faculty of Science BIOCEV, Charles University, Prague, Czech Republic
- 245 10
- $a Aspartate-β-hydroxylase and hypoxia marker expression in head and neck carcinomas: implications for HPV-associated tumors / $c J. Smahelova, B. Pokryvkova, E. Stovickova, M. Grega, O. Vencalek, M. Smahel, V. Koucky, S. Malerova, J. Klozar, R. Tachezy
- 520 9_
- $a BACKGROUND: A proportion of head and neck carcinomas (HNSCCs) are induced by high-risk human papillomaviruses (HPVs) and are associated with better patient outcomes compared to patients with HNSCCs related to tobacco and alcohol abuse. In the microenvironment of solid tumors, including HNSCCs, oxygen levels are often reduced, and a hypoxic state is induced. This can lead to a poor treatment response and a worse patient prognosis. One of the hypoxia-responsive genes is aspartate-β-hydroxylase (ASPH), whose activity promotes the growth, invasiveness, and metastasis of many types of solid tumors. METHODS: In our study, HNSCC samples were analyzed for the expression of ASPH and selected endogenous hypoxia markers by real-time PCR and/or multiplex fluorescence immunohistochemistry. RESULTS: Except for the EPAS1 gene, which had higher mRNA expression in the HPV-negative group of HNSCC (p < 0.05), we found no other differences in the expression of the tested genes that were related to HPV status. On the contrary, a statistically significantly higher number of cells producing ASPH (p < 0.0001), HIF1A (p < 0.0001), GLUT1 (p < 0.0001), and MMP13 (p < 0.05) proteins were detected in the HPV-positive tumor group than in the HPV-negative sample group. All the evaluated markers, except for MMP9/13, were more abundant in the tumor parenchyma than in the tumor stroma. The Cox proportional hazard models showed that increased numbers of cells with GLUT1 and HIF1A protein expression were positive prognostic markers for overall and disease-specific survival in patients independent of HPV tumor status. CONCLUSION: The study examined HNSCC samples and found that elevated ASPH and hypoxia marker proteins, typically associated with poor prognosis, may actually indicate active HPV infection, the strongest prognostic factor in HNSCC patients. In cases where HPV status is uncertain, increased expression of HIF1A and GLUT1 can serve as positive prognostic factors.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pokryvkova, Barbora $u Department of Genetics and Microbiology, Faculty of Science BIOCEV, Charles University, Prague, Czech Republic
- 700 1_
- $a Stovickova, Eliska $u Department of Genetics and Microbiology, Faculty of Science BIOCEV, Charles University, Prague, Czech Republic
- 700 1_
- $a Grega, Marek $u Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Vencalek, Ondrej $u Department of Mathematical Analysis and Applications of Mathematics, Faculty of Science, Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Smahel, Michal $u Department of Genetics and Microbiology, Faculty of Science BIOCEV, Charles University, Prague, Czech Republic
- 700 1_
- $a Koucky, Vladimir $u Department of Otorhinolaryngology and Head and Neck Surgery, First Medical Faculty, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Malerova, Simona $u Department of Otorhinolaryngology and Head and Neck Surgery, First Medical Faculty, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Klozar, Jan $u Department of Otorhinolaryngology and Head and Neck Surgery, First Medical Faculty, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Tachezy, Ruth $u Department of Genetics and Microbiology, Faculty of Science BIOCEV, Charles University, Prague, Czech Republic. tachezr@natur.cuni.cz
- 773 0_
- $w MED00165433 $t Infectious agents and cancer $x 1750-9378 $g Roč. 19, č. 1 (2024), s. 26
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38858774 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240723 $b ABA008
- 991 __
- $a 20240726151356 $b ABA008
- 999 __
- $a ok $b bmc $g 2125409 $s 1224434
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 19 $c 1 $d 26 $e 20240610 $i 1750-9378 $m Infectious agents and cancer $n Infect Agent Cancer $x MED00165433
- GRA __
- $a Inter-Excellence programme (No. LTAUSA18003) $p Ministry of Education, Youth and Sports, Czech Republic
- GRA __
- $a Programme EXCELES, ID Project No. LX22NPO5103 $p European Union - Next Generation EU
- GRA __
- $a SVV260679 $p Charles University, Prague, Czech Republic
- LZP __
- $a Pubmed-20240723